Sharing and archiving of GA mice

https://nc3rs.org.uk/sites/default/files/2022-01/Sharing%20%26%20archiving%20of%20genetically%20altered%20mice.pdf 1st November 2021

Guidance Overview

The use of genetically altered (GA) animals has become a mainstay of biomedical research, with new technical approaches (such as CRISPR/Cas9) accelerating the pace at which new animal models become available. This raises scientific, ethical and logistical issues, in terms of the generation, breeding, maintenance and use of these animals, together with challenges in terms of applying the principles of replacement, reduction and refinement (the 3Rs).

With this in mind, the NC3Rs established a working group, including international experts on breeding, managing and archiving colonies, to define best practice in breeding and colony management. As part of this agenda, a guidance document originally written in 2009 by the RSPCA (in association with the MRC, BBSRC, and the NC3Rs), has been updated to reflect how current best practices in the archiving and sharing of GA strains can provide an opportunity for reduction and refinement.

Although there is a focus on mice, as the most frequently used animal in biomedical research, the concepts in this guidance can be applied to all common purpose-bred laboratory species. For the purposes of this document, archiving is defined as the storage of frozen (cryopreserved) embryos or gametes which preserves the genetic stock and eliminates the need to maintain the stock as live animals. These cryopreserved resources are often the best means of sharing GA strains with other scientists, while avoiding the welfare concerns related to transporting live animals.

This document is intended to provide an overview of current best practice and includes a comprehensive list of resources for more detail on each topic.

(Text taken from https://nc3rs.org.uk/3rs-resources/breeding-and-colony-management/sharing-and-archiving-ga-mice)

Institute Authors

Group leader

Research topics & keywords

All publications

Filter by group
Filter by group leader
Filter by research topic
Filter by year
Search publications

https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2

Plasma signals of lung tumor promotion for molecular cancer prevention

25 June 2026

Institute Authors (1)

William Hill

Research Group

Cancer Origins

array(1) { [0]=> int(7954) }

https://link.springer.com/article/10.1038/s44319-026-00809-1

PKMYT1 has an important role in the timing and fidelity of chromosome segregation

5 June 2026

Institute Authors (5)

Asma Belbelazi, Charlie Greenaway-Wells, Zoe Edwards, Keren Dawson, Iain Hagan

Research Group

Cell Division

array(1) { [0]=> int(1855) }

https://www.nature.com/articles/s42255-026-01514-y

Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

27 April 2026

Institute Authors (4)

Amaya Virós, Noah Palombo, Charlotte Russell, Claus Jørgensen

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00114-5

Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity

13 April 2026

Institute Authors (1)

Samra Turajlić

Research Group

Cancer Dynamics

array(1) { [0]=> int(8377) }

https://www.nature.com/articles/s41467-026-69964-2

Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response

25 February 2026

Institute Authors (1)

Sylvain Delaunay

Research Group

RNA Dynamics in Cancer

array(1) { [0]=> int(2224) }

https://doi.org/10.1038/s44161-025-00740-z

Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes

11 November 2025

Institute Authors (6)

Robert Sellers, John Weightman, Wolfgang Breitwieser, Natalia Moncaut, Michael Lie-a-ling, Georges Lacaud

Labs & Facilities

Computational Biology Support, Molecular Biology, Genome Editing and Mouse Models

array(3) { [0]=> int(3839) [1]=> int(3827) [2]=> int(2947) }

Research Group

Stem Cell Biology

array(1) { [0]=> int(2449) }
Images of stained cells superimposed with headshot images of Samra Turajlic and Tim Somervaille
Image of skin cancer in ageing humans

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Two Institute Scientists elected to the Academy of Medical Sciences

We celebrate the recognition Professor Samra Turajlic and Professor Tim Somervaille by a prestigious medical science institution

New publication: Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

Research explores the role of lipid signalling in cancer behaviour

Cancer Research In the Paterson Building
Two Institute Scientists elected to the Academy of Medical Sciences
New publication: Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Institute life in Manchester

We strive to make our community a welcoming, caring and enthusiastic one, fuelling ambition with opportunities for training and mentoring to help us all achieve our personal and professional goals.

“We are so pleased to have received the funding to enable us to test our hypothesis in the lab. If we can create a new medicine that can precisely target a specific type of cell within the tumour, and restore anti-cancer immune responses, this will be a game-changer for oesophageal cancer patients “

Sara Valpione

Former Institute Clinical Fellow and now Clinician in Residence within the CRUK National Biomarker Centre

“My charity bake sales – known as “David’s Great British Bake Off” – are always a hit, home baked products taste so much better than shop bought and are greatly appreciated by staff!”

David Jenkins

Purchasing Officer

“We’ve seen some remarkable responses, with an improvement for some patients within days. This is an early phase trial so there’s a lot more work to do. But the data we have so far is very encouraging and could help many thousands of people in the future”

Tim Somervaille

Senior Group Leader

“It is a pleasure to introduce my team who work to deliver our research goals. We work in a friendly and collaborative environment, supporting each other’s projects.  “

Amaya Virós

CRUK Advanced Clinician Scientist Fellow